EDWARDS LIFESCIENCES CORP (EW:NYSE)
$84.55 -2.22 (-2.5585%)
Analysed EDWARDS LIFESCIENCES CORP (EW:NYSE) News Sources
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
01-09-2026
yahoo.com
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
04-09-2026
yahoo.com
Edwards Lifesciences Comments on TAVR National Coverage Decision
10-09-2026
yahoo.com
Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation
13-08-2026
yahoo.com
Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care
19-08-2026
yahoo.com
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
19-08-2026
yahoo.com
Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?
20-08-2026
yahoo.com
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
31-08-2026
barchart.com
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
02-09-2026
yahoo.com
Is Edwards Lifesciences Stock Underperforming the Dow?
08-09-2026
barchart.com
What is the current price of EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The current price of EDWARDS LIFESCIENCES CORP (EW:NYSE) is $84.55.
EDWARDS LIFESCIENCES CORP (EW:NYSE) absolute price change since previous trading day?
The absolute price change of EDWARDS LIFESCIENCES CORP (EW:NYSE) since the previous trading day is $-2.22.
EDWARDS LIFESCIENCES CORP (EW:NYSE) percentage price change since previous trading day?
The percentage price change of EDWARDS LIFESCIENCES CORP (EW:NYSE) since the previous trading day is -2.5585%.
What is the most recent average sentiment score for EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The most recent average sentiment score for EDWARDS LIFESCIENCES CORP (EW:NYSE) is 74 out of 100.
What is the most recent average sentiment for EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The most recent sentiment for EDWARDS LIFESCIENCES CORP (EW:NYSE) is .
SEC-8K** Filing Available For EDWARDS LIFESCIENCES CORP (EW:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.